1型糖尿病患者的生命阶段过渡
本文定义1型糖尿病全生命周期中的两个主要过渡期:新兴成人过渡(通常18-25岁,转向自我管理和成人照护)和老年过渡(年龄不定,出现合并症和并发症,需更多协助和血糖目标个体化)。提出包含八个共同领域的框架,讨论关键临床差距和研究需求。
要点
- 新兴成人过渡期通常为18-25岁,重点为自我管理和转入成人照护。
- 老年过渡期年龄不定,重点为合并症管理和血糖目标个体化。
- 八个共同领域涵盖医疗团队需求、教育支持、生理适应、神经认知、功能状态等。
核心结论
- 1型糖尿病存在新兴成人过渡和老年过渡两个主要生命阶段过渡,需利用其相似性改善全生命周期照护。
研究设计与样本
- 本文为Personal View,未报告系统检索范围或样本量。
主要发现
- 新兴成人过渡通常发生在18至25岁,涉及向自我管理和成人照护转移。
- 老年过渡发生在可变年龄,因合并症和并发症可能需要更多管理协助和血糖目标定制。
- 两个过渡期共有八个领域:医疗团队需求、自我管理教育与支持、生理适应、合并症、神经认知生理与能力、功能状态与活动水平、独立程度、财务背景。
临床怎么用
- 临床应识别1型糖尿病患者所处的生命阶段过渡,针对八个领域评估需求并提供相应支持。
局限性
- 本文为Personal View,未提供原始研究数据或系统评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 1 diabetes affects individuals of all ages, with different clinical priorities and support needs at different stages of life. In this Personal View, we define the two major transitions that occur across the lifespan in type 1 diabetes: the emerging adult transition (typically occurring between age 18 years and age 25 years, as individuals transition to self-management and transfer to adult care), and the older adult transition (occurring at variable ages as individuals develop comorbidities and complications that could require increased assistance with management and customisation of glycaemic targets). We identify a framework considering these life stage transitions, including eight domains common to both stages. These domains include the following: needs from the medical care team, diabetes self-management education and support needs, adapting diabetes management to evolving physiology, comorbidities affecting self-care and diabetes management, changing neurocognitive physiology and self-management capabilities, functional status and activity levels, degrees of independence (living situations and social support), and changing financial context. We discuss key clinical gaps and research needs, focusing on how the similarities in these major transitions can be leveraged to improve care for people with type 1 diabetes across the lifespan.
引用
- Vitale RJ, Toschi E, Ortega J, et al. Life stage transitions for people with type 1 diabetes. Lancet Diabetes Endocrinol. 2025. PMID: 41233045. doi:10.1016/S2213-8587(25)00298-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。